MRAS antibody
Principal name
MRAS antibody
Alternative names for MRAS antibody
Ras-related protein R-Ras3, RRAS3, M-Ras
Ncbi ID
9606, NP_036351.3, NP_001078518.1, NP_036351, NP_001078518, NM_008624, NM_012219, NM_001085049, NP_032650.1
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of MRAS antibody
- Kit Component:
- - KN310277G1, Mras gRNA vector 1 in pCas-Guide vector
- KN310277G2, Mras gRNA vector 2 in pCas-Guide vector
- KN310277D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Rodriguez-Viciana P., et al (2006) Mol. Cell 22:217-230Quilliam LA, et al. (1999) J Biol Chem 274 (34): 23850-7.
Western Blot analysis of MRAS expression in transfected 293T cell line (H00022808-T01) by MRAS MaxPab polyclonal antibody.Lane 1: MRAS transfected lysate(22.88 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of MRAS expression in transfected 293T cell line (H00022808-T01) by MRAS MaxPab polyclonal antibody.Lane 1: MRAS transfected lysate(22.88 KDa).Lane 2: Non-transfected lysate.
Anti-MRAS mouse monoclonal antibody (TA502864) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY MRAS(RC212259 ).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MRAS (RC212259, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MRAS.
Flow cytometric Analysis of Jurkat cells, using anti-MRAS antibody(TA502864),(Red), compared to a nonspecific negative control antibody,(Blue).
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA502864 | MRAS antibody |
||||||
| MRAS mouse monoclonal antibody, clone OTI3C4 (formerly 3C4) | |||||||
 |
Mouse | IgG2a | OTI3C4 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP312259 | MRAS (transcript variant 1) |
||||
| Recombinant protein of human muscle RAS oncogene homolog (MRAS), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP318272 | MRAS (transcript variant 2) |
||||
| Recombinant protein of human muscle RAS oncogene homolog (MRAS), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760665 | MRAS (full length, N-term HIS tag, transcript variant 1) |
||||
| Purified recombinant protein of Human muscle RAS oncogene homolog (MRAS), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR202224L1V | Lenti ORF particles, Mras (Myc-DDK-tagged) - Mouse muscle and microspikes RAS (Mras), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||